000 01600 a2200445 4500
005 20250517164414.0
264 0 _c20180514
008 201805s 0 0 eng d
022 _a1543-8392
024 7 _a10.1021/acs.molpharmaceut.7b00233
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAttarwala, Husain
245 0 0 _aCosilencing Intestinal Transglutaminase-2 and Interleukin-15 Using Gelatin-Based Nanoparticles in an in Vitro Model of Celiac Disease.
_h[electronic resource]
260 _bMolecular pharmaceutics
_c09 2017
300 _a3036-3044 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCaco-2 Cells
650 0 4 _aCeliac Disease
_xgenetics
650 0 4 _aCell Line
650 0 4 _aGTP-Binding Proteins
_xgenetics
650 0 4 _aGelatin
_xchemistry
650 0 4 _aGene Silencing
650 0 4 _aHumans
650 0 4 _aInterferon-gamma
_xmetabolism
650 0 4 _aInterleukin-15
_xgenetics
650 0 4 _aIntestinal Mucosa
_xmetabolism
650 0 4 _aIntestines
_xenzymology
650 0 4 _aMice
650 0 4 _aNanoparticles
_xchemistry
650 0 4 _aProtein Glutamine gamma Glutamyltransferase 2
650 0 4 _aRNA, Small Interfering
_xmetabolism
650 0 4 _aTransglutaminases
_xgenetics
650 0 4 _aTumor Necrosis Factor-alpha
_xmetabolism
700 1 _aClausen, Valerie
700 1 _aChaturvedi, Prasoon
700 1 _aAmiji, Mansoor M
773 0 _tMolecular pharmaceutics
_gvol. 14
_gno. 9
_gp. 3036-3044
856 4 0 _uhttps://doi.org/10.1021/acs.molpharmaceut.7b00233
_zAvailable from publisher's website
999 _c27396902
_d27396902